CLINICAL_TRIALS
trial_result
· 2022-03-08
Clinical Trial Update: Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis [Phase 2]
Summary
Phase 2 trial assessing efficacy and safety of namilumab for moderate-to-severe axial spondyloarthritis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Izana Bioscience Ltd. | Conditions: Axial Spondyloarthritis | Phase 2 | Status: COMPLETED | Results posted: 2022-03-08